Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

18.191.254.51
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-
Alagille Syndrome
Journal Scan
Progressive Familial Intrahepatic Cholestasis

ALGS may lead to lower Full Scale IQ

Posted on

Patients with Alagille syndrome (ALGS) are at an increased risk of lower Full Scale IQ (FSIQ) whereas patients with progressive familial intrahepatic cholestasis (PFIC) and alpha 1 antitrypsin deficiency (A1AT) are not, according to a study.

Deficits in working memory and processing speed were noted in patients with ALGS and A1AT.

This longitudinal, multicenter study examined the FSIQ of 70 patients with ALGS, 43 with PFIC, and 102 with A1AT.

-Advertisement-
-Advertisement-

Mean FSIQ in patients ALGS was 94 compared to 101 in patients with A1AT (P = 0.01).

Patients with ALGS had the highest frequency of FSIQ <85 at 29% followed by patients with PFIC at 18.6% and patients with A1AT at 12.8%. The frequency was greater than expected in ALGS.

Patients with ALGS scored significantly lower than normal in most composites whereas patients with A1AT scored lower on Working Memory and Processing Speed.

Total bilirubin, alkaline phosphatase, albumin, hemoglobin, and parental education were significantly associated with FSIQ.

Reference
Leung DH, Sorensen LG, Ye W, Hawthorne K, et al; Childhood Liver Disease Research Network (ChiLDReN). Neurodevelopmental Outcomes in Children with Inherited Liver Disease and Native Liver. J Pediatr Gastroenterol Nutr. 2021;doi: 10.1097/MPG.0000000000003337. Epub ahead of print. PMID: 34694263.

-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-